| EASD: Novel DPP-4 Drug Works in Renal Impairment - MedPage Today |
|
|
MedPage TodayIn a phase III study of patients who couldn't take metformin because of the drug's GI side effects or renal impairment, linagliptin effectively reduced ...Diabetes drug safety boost Pharmacy NewsNew data support safety profile of diabetes drug Nursing in PracticeBoehringer Ingelheim Presents New Phase III Data Evaluating Linagliptin in ... read more |